AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Perceptions and recommendations of physicians/KOLs on value added medicines

21 November 2019

Report

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

7 October 2019

Report

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

A digital future for value added medicines

24 September 2019

Policy, Report

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Addressing medicine shortages in Europe

29 September 2017

Report

Position paper Reading list Commentary + EIU document

2017 Market Review – Biosimilar Medicines Markets – Policy Overview

12 September 2017

Report

Value Added Medicines: Time to Adjust the HTA Decision Frameworks

5 September 2017

Report